[Donohue syndrome and use of continuous subcutaneous IGF1 pump therapy]

MLA

M. A. Melikyan, et al. “[Donohue Syndrome and Use of Continuous Subcutaneous IGF1 Pump Therapy].” Problemy Endokrinologii, vol. 68, no. 5, Apr. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ed7fa55586c2c276399b81a22d12dd9e&authtype=sso&custid=ns315887.

APA

M. A. Melikyan, T. E. Ivannikova, N. V. Milovanova, A. A. Kolodkina, O. B. Bezlepkina, & N. G. Mokryshevа. (2022). [Donohue syndrome and use of continuous subcutaneous IGF1 pump therapy]. Problemy Endokrinologii, 68(5).

Chicago

M. A. Melikyan, T. E. Ivannikova, N. V. Milovanova, A. A. Kolodkina, O. B. Bezlepkina, and N. G. Mokryshevа. 2022. “[Donohue Syndrome and Use of Continuous Subcutaneous IGF1 Pump Therapy].” Problemy Endokrinologii 68 (5). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ed7fa55586c2c276399b81a22d12dd9e&authtype=sso&custid=ns315887.